Analysis of T2 intensity by magnetic resonance imaging of deep gray matter nuclei in multiple sclerosis patients: effect of immunomodulatory therapies.

Pawate S, Wang L, Song Y, Sriram S
J Neuroimaging. 2012 22 (2): 137-44

PMID: 21707826 · DOI:10.1111/j.1552-6569.2011.00622.x

MeSH Terms (19)

Adult Antibodies, Monoclonal, Humanized Cerebellar Nuclei Female Glatiramer Acetate Globus Pallidus Humans Immunologic Factors Interferon-beta Magnetic Resonance Imaging Male Middle Aged Multiple Sclerosis Mycophenolic Acid Natalizumab Peptides Red Nucleus Retrospective Studies Substantia Nigra

Connections (2)

This publication is referenced by other Labnodes entities:

Links